Causes of Disqualification of Egyptian Potential Living Liver Donors
NCT ID: NCT01809249
Last Updated: 2013-03-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
192 participants
OBSERVATIONAL
2010-06-30
2012-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Health Related Quality of Life Assessment In Egyptian Recipients After Living Donor Liver Transplantation
NCT01784497
Single Center Experience Over a Decade in Living Donor Liver Transplantation for Egyptian Patients With Hepatocellular Carcinoma: Stretching the Limits
NCT01937286
Role of Tissue C4d in Differentiation Between Acut e Rejection and HCV Recurrence After Liver Transplantation
NCT02209675
Transcranial Doppler During Liver Transplantation
NCT05144451
Ischemia Time and Graft Survival
NCT02521584
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Age between 18 and 50 years
2. Relationship within 3rd degree of consanguinity with recipient or spouse.
3. The donor-recipient pair must be blood group compatible.
4. An informed consent should be obtained.
Exclusion Criteria
* Underlying medical condition (diabetes, cardiopulmonary disease, etc.).
* ABO incompatibility
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Iman Fawzy Montasser
Lecturer of Tropical Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ain Shams Center For Organ Transplantation (ASCOT),Ain Shams university
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Donar Safety
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.